SARS-CoV-2 Omicron Antibody

Product Description

SARS-CoV-2 Omicron Antibody
Catalog number: B2010592
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: 150 kDa
Supplied as: Solution
Applications: molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants
Storage: -20C
Keywords: SARS-CoV-2 Spike Antibody, Omicron Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

Download SARS-CoV-2 Brochure

References:
1: Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G,
Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M. Evolution patterns of
SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun. 2021
Jan 29;538:88-91.

2: Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on
structure, pathogenicity and immunity aspects of pandemic human coronaviruses.
Infect Genet Evol. 2020 Nov;85:104502.

3: Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: Structure,
Biology, and Structure-Based Therapeutics Development. Front Cell Infect
Microbiol. 2020 Nov 25;10:587269.

4: Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and
Pathogenesis. Trends Immunol. 2020 Dec;41(12):1100-1115.

5: Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat
Rev Microbiol. 2021 Mar;19(3):141-154.

6: Finkel Y, Mizrahi O, Nachshon A, Weingarten-Gabbay S, Morgenstern D, Yahalom-
Ronen Y, Tamir H, Achdout H, Stein D, Israeli O, Beth-Din A, Melamed S, Weiss S,
Israely T, Paran N, Schwartz M, Stern-Ginossar N. The coding capacity of SARS-
CoV-2. Nature. 2021 Jan;589(7840):125-130.

7: Bakhiet M, Taurin S. SARS-CoV-2: Targeted managements and vaccine
development. Cytokine Growth Factor Rev. 2021 Apr;58:16-29.

8: Sanyal S. How SARS-CoV-2 (COVID-19) spreads within infected hosts – what we
know so far. Emerg Top Life Sci. 2020 Dec 11;4(4):371-378.

9: Campos DMO, Fulco UL, de Oliveira CBS, Oliveira JIN. SARS-CoV-2 virus
infection: Targets and antiviral pharmacological strategies. J Evid Based Med.
2020 Nov;13(4):255-260.

10: Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao
Z. SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal
swabs specimens. J Med Virol. 2020 Sep;92(9):1676-1680.

11: Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a
global pandemic: Understanding the epidemiology, immune response and potential
therapeutic targets of SARS-CoV-2. Biochimie. 2020 Dec;179:85-100.

12: Yang Q, Hughes TA, Kelkar A, Yu X, Cheng K, Park S, Huang WC, Lovell JF,
Neelamegham S. Inhibition of SARS-CoV-2 viral entry upon blocking N- and
O-glycan elaboration. Elife. 2020 Oct 26;9:e61552.

13: Rahbari R, Moradi N, Abdi M. rRT-PCR for SARS-CoV-2: Analytical
considerations. Clin Chim Acta. 2021 May;516:1-7.

14: Zapor M. Persistent Detection and Infectious Potential of SARS-CoV-2 Virus
in Clinical Specimens from COVID-19 Patients. Viruses. 2020 Dec 3;12(12):1384.

15: Gao J, Quan L. Current Status of Diagnostic Testing for SARS-CoV-2 Infection
and Future Developments: A Review. Med Sci Monit. 2020 Dec 17;26:e928552.

16: Flower TG, Buffalo CZ, Hooy RM, Allaire M, Ren X, Hurley JH. Structure of
SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein. Proc Natl Acad Sci U
S A. 2021 Jan 12;118(2):e2021785118.

17: Hossain MG, Javed A, Akter S, Saha S. SARS-CoV-2 host diversity: An update
of natural infections and experimental evidence. J Microbiol Immunol Infect.
2021 Apr;54(2):175-181.

18: Boretti A. Favipiravir use for SARS CoV-2 infection. Pharmacol Rep. 2020
Dec;72(6):1542-1552.

19: Awadasseid A, Wu Y, Tanaka Y, Zhang W. SARS-CoV-2 variants evolved during
the early stage of the pandemic and effects of mutations on adaptation in Wuhan
populations. Int J Biol Sci. 2021 Jan 1;17(1):97-106.
20: Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y, Wang S, Deng G, Zhou H, Wu Y.
Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-
CoV-2 infection. Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4.

Products Related to SARS-CoV-2 Omicron Antibody: Antibodies